comparemela.com
Home
Live Updates
XNK Therapeutics gets abstract on ACP-001 selected for presentation at EHA2022 : comparemela.com
XNK Therapeutics gets abstract on ACP-001 selected for presentation at EHA2022
/PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced that an abstract on the long-term follow-up of the Phase I/II clinical trial study ACP-001 with its...
Related Keywords
Sweden ,
Austria ,
Vienna ,
Wien ,
Stockholm ,
Stephan Meinke ,
Johan Aschan ,
Sarclisa Isatuximab ,
Johan Lund ,
Hans Gustaf Ljunggren ,
Henrik Holmqvist ,
Johan Liwing ,
Evren Alici ,
Hareth Nahi ,
Karolinska University Hospital ,
Hematology Center ,
European Hematology Association ,
Multiple Myeloma ,
Long Term Follow Up ,
Per Henrik Holmqvist ,
Xnk Therapeutics Ab ,
comparemela.com © 2020. All Rights Reserved.